MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia.
This study has been completed.
Sponsor:
Merck
Information provided by:
Merck
ClinicalTrials.gov Identifier:
NCT00482430
First received: May 31, 2007
Last updated: November 4, 2008
Last verified: November 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Primary Completion Date: | October 2008 (Final data collection date for primary outcome measure) |